APA (7th ed.) Citation

SL, R., S, B., MP, B., K, U., S, H., P, G., . . . AM, B. (2019). Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC. Lung cancer (Amsterdam, Netherlands), 135, 217. https://doi.org/10.1016/j.lungcan.2019.07.006

Chicago Style (17th ed.) Citation

SL, Ryan, et al. "Targeting NF-κB-mediated Inflammatory Pathways in Cisplatin-resistant NSCLC." Lung Cancer (Amsterdam, Netherlands) 135 (2019): 217. https://doi.org/10.1016/j.lungcan.2019.07.006.

MLA (9th ed.) Citation

SL, Ryan, et al. "Targeting NF-κB-mediated Inflammatory Pathways in Cisplatin-resistant NSCLC." Lung Cancer (Amsterdam, Netherlands), vol. 135, 2019, p. 217, https://doi.org/10.1016/j.lungcan.2019.07.006.